FILING ANALYSIS · MONDAY, NOVEMBER 16

Jaguar Health, Inc. JAGX — 8-K: Results of Operations and Financial Condition

neutral

Jaguar Health reported a reduced net loss of $5.83 million in Q3 2026, with total revenue decreasing 24% year-over-year to $2.34 million, and the company significantly reduced its outstanding debt balance by $10.1 million during the quarter.

The filing

8-K - Jaguar Health, Inc. (0001585608) (Filer)

Read the filing on SEC EDGAR →

How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.

Get filings like this every market day

The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.

Subscribe free →
All analyses · Earnings today · Latest brief · Track record
© 2026 Dutchcode B.V. · Built by
Blinkof.ai verified — grade A+